Swiss Life Group takes over Germany's leading independent provider of real estate-related services, CORPUS SIREO, with retroactive effect as of 1 January 2014, thus further developing its position in the field of real estate asset management. The sellers are three German savings bank institutions, namely Sparkasse KölnBonn (50%), Stadtsparkasse Düsseldorf (25%) and Frankfurter Sparkasse (25%). The transaction is to be completed in the second half of 2014; however, it is still subject to clearance by the cartel authorities.

Osborne Clarke has advised longstanding client LDC and Newco on a £50m management buyout (MBO) of Clifford Thames.

LDC is the UK's leading regional mid-market private equity house, with a current portfolio of more than 80 businesses valued in excess of £2billion.

Clifford Thames creates, aggregates and publishes aftermarket data for labour operations, part catalogues and vehicle specifications. It is one of the UK's market leading firms in automotive data.

Freshfields Bruckhaus Deringer has advised CITIC Pacific on its acquisition of all of the issued share capital of CITIC Limited from mainland-based CITIC Group and its subsequent share placement to 27 professional and international investors for a total amount of US$6.8bn to settle part of the consideration of the acquisition.

The US$36.5bn asset injection was initially announced on the Hong Kong Stock Exchange in April, and has been completed together with the share placement this week.

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, has announced that it has acquired Covagen AG, a privately held biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform. Cravath represented Cilag GmbH in connection with this transaction. Financial terms were not disclosed.

Simpson Thacher is representing Japan’s Murata Manufacturing Co., Ltd. in its acquisition of the entire equity interest in NASDAQ-listed Peregrine Semiconductor Corp. Murata Electronics North America, Inc., a wholly-owned subsidiary of Murata, will acquire Peregrine for a transaction value of approximately US$465 million, or US$12.50 per share in cash. The transaction, which is subject to Peregrine’s stockholder approval, regulatory approvals and other customary closing conditions, is expected to close by the end of 2014 or early 2015.

Yorkshire-based sealants and adhesives manufacturer, Bond It, has been acquired by India-based Astral Poly Technik in a £4.4m deal. Based in Elland, Bond IT also specialises in producing waterproofing products, roofing compounds, polyurethanes, adhesive tapes and grouts.

The Bond It brand, which is owned by Seal IT Services Limited, is also the main sponsor of the Huddersfield Giants Rugby Club.

Davis Polk is advising Roche in connection with its $8.3 billion acquisition of InterMune, Inc. The closing of the transaction is expected to take place in 2014.

Headquartered in Basel, Switzerland, Roche is a leader in research-focused health care with combined strengths in pharmaceuticals and diagnostics. InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.

Kirkland & Ellis LLP represents Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY), which announced today it has signed a definitive agreement with International Rectifier Corporation (NYSE: IRF), under which Infineon will acquire International Rectifier for US$40 per share in an all-cash transaction valued at approximately US$3.0 billion. The closing of the transaction is subject to regulatory approvals in various jurisdictions and customary closing conditions, as well as approval of International Rectifier stockholders.

uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, has announced the acquisition of InoCard GmbH, an innovative, early-stage biotechnology company focused on the development of gene therapy approaches for cardiac disease. InoCard has developed a novel gene therapy to preclinical proof of concept, for the one-time treatment of congestive heart failure (CHF), a rapidly progressing disease affecting 26 million people worldwide. InoCard founders Prof. Patrick Most and Prof.

IBM has acquired the business operations of Lighthouse Security Group, LLC, a premier cloud security services provider. Lighthouse Security Group is a subsidiary of long-ime IBM business partner Lighthouse Computer Services, Inc. Cravath represented IBM in connection with this transaction. Financial terms were not disclosed.